Cytokeratin 19 (A53-B/A2.26) Mouse Monoclonal Antibody

Cytokeratin 19
Cytokeratin 19 antibody detects the antigen in the cytoplasm of papillary carcinoma of the thyroid.

Cytokeratin 19 (A53-B/A2.26) Mouse Monoclonal Antibody

Specialties: Anatomic Pathology

Updated: 2017-05-24 08:46:09

Anti-cytokeratin 19 reacts with epithelia and epithelial malignancies including carcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast.1 Anti-cytokeratin 19 is very useful in differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma, especially in a combination of cytokeratin 7, CAM5.2l, Ber-EP4/MOC31, HepPar1 and TTF1.1 Another useful application is the identification of thyroid papillary carcinoma.2-3

  1. Jain R, et al. Appl Immunohistochem Mol Morphol. 2010; 18:9-15.
  2. Rosai J. Tumori. 2003; 89:517-9.
  3. de Matos LL, et al. Diagn Pathol. 2012; 7:97.

Specifications


  • Reactivity: paraffin
  • Visualization: cytoplasmic
  • Control: bladder, colon carcinoma, colon, thyroid carcinoma
  • Dilution Range: 1:100-1:500*

Package Inserts


IFU SDS

Ordering Information

For in vitro diagnostic (IVD) use in USA

0.1 mL concentrate319M-14
0.5 mL concentrate319M-15
1 mL concentrate319M-16
1 mL predilute319M-17
7 mL predilute319M-18

For in vitro diagnostic (IVD) use in Canada

0.1 mL concentrate319M-14
0.5 mL concentrate319M-15
1 mL concentrate319M-16
1 mL predilute319M-17
7 mL predilute319M-18

For in vitro diagnostic (IVD) use in Europe

0.1 mL concentrate319M-14
0.5 mL concentrate319M-15
1 mL concentrate319M-16
1 mL predilute319M-17
7 mL predilute319M-18

For research use only (RUO) in Japan

0.1 mL concentrate319M-14-RUO
0.5 mL concentrate319M-15-RUO
1 mL concentrate319M-16-RUO
1 mL predilute319M-17-RUO
7 mL predilute319M-18-RUO

 

To request information on this product in additional countries, please click the button below.

Request More Information